These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 12174591)

  • 1. [Specific features of p53 protein induction after ionizing radiation in cells of patients with Nijmegen breakage syndrome].
    Balmukhanov TS; Aĭtkhozhina NA; Matsuura S; Komatsu K; Weemas C
    Genetika; 2002 Jul; 38(7):980-4. PubMed ID: 12174591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation induction of p53 in cells from Nijmegen breakage syndrome is defective but not similar to ataxia-telangiectasia.
    Matsuura K; Balmukhanov T; Tauchi H; Weemaes C; Smeets D; Chrzanowska K; Endou S; Matsuura S; Komatsu K
    Biochem Biophys Res Commun; 1998 Jan; 242(3):602-7. PubMed ID: 9464263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of cell cycle checkpoint responses after ionizing radiation in Nijmegen breakage syndrome cells.
    Yamazaki V; Wegner RD; Kirchgessner CU
    Cancer Res; 1998 Jun; 58(11):2316-22. PubMed ID: 9622065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation by ionizing radiation of CDC2, cyclin A, cyclin B, thymidine kinase, topoisomerase IIalpha, and RAD51 expression in normal human diploid fibroblasts is dependent on p53/p21Waf1.
    de Toledo SM; Azzam EI; Keng P; Laffrenier S; Little JB
    Cell Growth Differ; 1998 Nov; 9(11):887-96. PubMed ID: 9831241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDC2 is down-regulated by ionizing radiation in a p53-dependent manner.
    Azzam EI; de Toledo SM; Pykett MJ; Nagasawa H; Little JB
    Cell Growth Differ; 1997 Nov; 8(11):1161-9. PubMed ID: 9372239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of SV40 immortalization of human fibroblasts on p53-dependent radiation responses.
    Kohli M; Jorgensen TJ
    Biochem Biophys Res Commun; 1999 Apr; 257(1):168-76. PubMed ID: 10092528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered centrosomes in ataxia-telangiectasia cells and rapamycin-treated Chinese hamster cells.
    Bonatti S; Simili M; Benedetti PA; Morandi F; Menichini P; Del Carratore R; Barale R; Abbondandolo A
    Environ Mol Mutagen; 2005 Oct; 46(3):164-73. PubMed ID: 15920752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nijmegen breakage syndrome cells fail to induce the p53-mediated DNA damage response following exposure to ionizing radiation.
    Jongmans W; Vuillaume M; Chrzanowska K; Smeets D; Sperling K; Hall J
    Mol Cell Biol; 1997 Sep; 17(9):5016-22. PubMed ID: 9271379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose-rate radiation attenuates the response of the tumor suppressor TP53.
    Ohnishi T; Wang X; Takahashi A; Ohnishi K; Ejima Y
    Radiat Res; 1999 Mar; 151(3):368-72. PubMed ID: 10073676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of the p53 pathway in response to ionizing radiation in uveal melanoma.
    Sun Y; Tran BN; Worley LA; Delston RB; Harbour JW
    Invest Ophthalmol Vis Sci; 2005 May; 46(5):1561-4. PubMed ID: 15851551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of p53 protein stabilization in cells of patients with ataxia-telangiectasia after gamma-irradiation].
    Spivak IM; Smirnova NV; Pleskach NM; Ledashcheva TA; Mikhel'son VM
    Tsitologiia; 2005; 47(10):898-906. PubMed ID: 16711389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [P53-status of cells from patients with progeria and ataxia-telangiectasia exposed to ionizing irradiation].
    Smirnova NV; Spivak IM; Mikhel'son VM
    Tsitologiia; 1999; 41(8):721-8. PubMed ID: 10563391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differing responses of Nijmegen breakage syndrome and ataxia telangiectasia cells to ionizing radiation.
    Little JB; Nagasawa H; Dahlberg WK; Zdzienicka MZ; Burma S; Chen DJ
    Radiat Res; 2002 Sep; 158(3):319-26. PubMed ID: 12175309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ionizing radiation and cell cycle progression in ataxia telangiectasia.
    Beamish H; Khanna KK; Lavin MF
    Radiat Res; 1994 Apr; 138(1 Suppl):S130-3. PubMed ID: 8146316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose fractionated radiation potentiates the effects of Paclitaxel in wild-type and mutant p53 head and neck tumor cell lines.
    Dey S; Spring PM; Arnold S; Valentino J; Chendil D; Regine WF; Mohiuddin M; Ahmed MM
    Clin Cancer Res; 2003 Apr; 9(4):1557-65. PubMed ID: 12684432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ionizing radiation induces a p53-dependent apoptotic mechanism in ARPE-19 cells.
    Jiang YL; Escaño MF; Sasaki R; Fujii S; Kusuhara S; Matsumoto A; Sugimura K; Negi A
    Jpn J Ophthalmol; 2004; 48(2):106-14. PubMed ID: 15064971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose response of gamma rays and iron nuclei for induction of chromosomal aberrations in normal and repair-deficient cell lines.
    George KA; Hada M; Jackson LJ; Elliott T; Kawata T; Pluth JM; Cucinotta FA
    Radiat Res; 2009 Jun; 171(6):752-63. PubMed ID: 19580482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ataxia-telangiectasia: chronic activation of damage-responsive functions is reduced by alpha-lipoic acid.
    Gatei M; Shkedy D; Khanna KK; Uziel T; Shiloh Y; Pandita TK; Lavin MF; Rotman G
    Oncogene; 2001 Jan; 20(3):289-94. PubMed ID: 11313957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA double-strand break induction and repair in irradiated lymphoblastoid, fibroblast cell lines and white blood cells from ATM, NBS and radiosensitive patients.
    Strasser H; Grabenbauer GG; Sprung CN; Sauer R; Distel LV
    Strahlenther Onkol; 2007 Aug; 183(8):447-53. PubMed ID: 17680225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased radiation-induced apoptosis and altered cell cycle progression of human lung cancer cell lines by antisense oligodeoxynucleotides targeting p53 and p21(WAF1/CIP1).
    Sak A; Wurm R; Elo B; Grehl S; Pöttgen C; Stüben G; Sinn B; Wolf G; Budach V; Stuschke M
    Cancer Gene Ther; 2003 Dec; 10(12):926-34. PubMed ID: 14712319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.